Z-1440-2017 Class II Terminated
FDA device recall Z-1440-2017 was initiated by Becton Dickinson & Company on Dec 20, 2016 and is designated Class II. Reason for recall: BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries. The recall status is terminated (terminated Apr 20, 2018). Affected quantity: 263 mm units.
Recall details
- Product Type
- Devices
- Report Date
- Mar 22, 2017
- Initiation Date
- Dec 20, 2016
- Termination Date
- Apr 20, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 263 mm units
Product description
Eclipse Hypodermic Needle
Reason for recall
BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries.
Distribution pattern
US Nationwide
Code information
N/A
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1440-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026